Key result
Dibenzoylmethane and its analogs inhibit BK Ca channels via pore blockade requiring structural rigidity.
Why the study?
BK Ca dysfunction is linked to multiple diseases, but the number of selective channel modulators remains limited.
DBM and its analogs are identified as novel, selective pore blockers of BK Ca channels, providing promising chemical scaffolds for future pharmacological development.
Provides BKCa pore blocker scaffolds for research; hypothesis-generating with no clinical implications yet.
Large-conductance calcium-activated potassium (BK Ca ) channels are ubiquitously expressed in mammalian cells and regulate electrical activity, intracellular calcium signaling, and cell survival. Although BK Ca dysfunction has been linked to multiple diseases, the number of selective channel modulators is limited. In this study, we characterize dibenzoylmethane (DBM), a plant-derived compound isolated from Hottonia palustris , as a novel inhibitor of BK Ca channel activity in both plasma membrane and mitochondrial BK Ca . Electrophysiological recordings revealed that DBM lowers the open probability of BK Ca channels in a concentration-dependent fashion and markedly reduces mean open time, leading to a pronounced flickering behavior - hallmarks of pore-targeted blockade. Competition experiments demonstrated that DBM antagonizes the effect of paxilline, a high-affinity pore-binding inhibitor, suggesting overlapping binding sites. Molecular dynamics simulations further supported this hypothesis, showing that several DBM molecules can block the pore by employing π-π interactions with each other and pore residues. On top of the pore, the carbonyl groups of DBM block the nearest potassium ion in the selectivity filter. The presence of DBM induces the removal of water molecules from the pore. To assess the structural requirements for activity, we tested three DBM analogs: phenyl-1,3-butanedione (PBD), trans -chalcone (T-Ch), and (E)-1,3-diphenylprop-2-en-1-ol (DPE). T-Ch and DPE inhibited BK Ca channels with comparable efficacy to DBM, whereas PBD was significantly less potent. These results indicate that diphenyl substitution and structural rigidity are critical determinants of inhibitory activity. Our findings position DBM and its analogs as promising chemical scaffolds for the development of selective BK Ca channel modulators with potential pharmacological applications.
No takes yet. Share an insight, caveat, or question.
Koprowski et al. (2026) studied this question. Dibenzoylmethane (DBM) vs. Paxilline, PBD, T-Ch, DPE was evaluated on BK Ca channel activity (open probability and mean open time). Dibenzoylmethane (DBM) and its analogs T-Ch and DPE inhibit BK Ca channels by acting as pore blockers, with diphenyl substitution and structural rigidity being critical for inhibitory activity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: